Live view of SEC fundamentals with peer-based benchmarks and implied valuation gaps.
Blend averages both multiples when available.
Current vs implied
If Thermo Fisher Scientific Inc. traded at Danaher Corporation P/E multiple, the stock price would be $749.60 (vs $618.72).
Implied from P/E
$749.60
Implied from P/S
$816.21
Bottom-right quadrant is the sweet spot: high growth, low valuation.
| Metric | TMO | Delta vs DHR | DHR | Context |
|---|---|---|---|---|
Revenue growth (LTM) | 0.1% | 181.8% higher | -0.1% | Growth edge |
Gross margin | 17.1% | 71.2% lower | 59.5% | Pricing power |
EBITDA margin | 30.4% | 5.1% lower | 32.1% | Operating leverage |
EV/Revenue | 5.81x | 17.5% lower | 7.04x | Multiple discount |
P/E | 37.79x | 16.7% lower | 45.35x | Value edge |
Net debt / EBITDA | 1.0 | 328.3% higher | -0.5 | Lower leverage |
Quality signals that explain why a cheap stock might stay cheap.
Partial coverage: 8/9 checks
TMO CIK: 97745
DHR CIK: 313616
